Research Grant
[Cite as http://purl.org/au-research/grants/nhmrc/1062638]
Researchers:
Dr Mandana Nikpour
(Principal investigator)
,
A/Pr David Prior
,
A/Pr Peter Nash
,
A/Pr Susanna Proudman
,
Dr Jane Zochling
,
View all 10 related researchers
Brief description Scleroderma is an autoimmune disease that shortens life span by over 30 years. The main cause of death is pulmonary arterial hypertension (PAH), a condition of increased pressure in the lung vessels. Even in the era of 'advanced' PAH therapy, only 50% of patients are alive beyond 5 years. Formation of clots in the small blood vessels of the lung plays a major role in the development of PAH. In this clinical trial we aim to determine whether anticoagulation (treatment to prevent clotting) improves survival in scleroderma PAH.
Funding Amount $AUD 1,190,521.83
Funding Scheme Project Grants
Notes Standard Project Grant
- PURL : http://purl.org/au-research/grants/nhmrc/1062638
- nhmrc : 1062638